Position in OGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,448,454
+$1,254,133 QoQ
Shares Held
106,976
+229.8% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#129
of 626 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $8,073,972,287 across 18 Drug Manufacturers - General names. OGN ranks #15 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,143,891 | $1,372,017,294 | |
| 2 | ABBV |
AbbVie Inc.
|
5,015,515 | $1,262,104,193 | |
| 3 | AZN |
Astrazeneca PLC
|
6,592,403 | $1,250,051,454 | |
| 4 | JNJ |
Johnson & Johnson
|
4,651,595 | $1,181,365,579 | |
| 5 | MRK |
Merck & Co., Inc.
|
6,793,897 | $873,015,763 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
5,113,242 | $646,006,993 | |
| 7 | AMGN |
Amgen Inc
|
1,326,673 | $480,414,824 | |
| 8 | PFE |
Pfizer Inc
|
16,746,801 | $403,262,965 |
All Filings in OGN
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,448,454 | 106,976 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $194,321 | 32,441 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $472,502 | 65,900 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,361,164 | 127,450 | Shares | Defined | 2026-03-31 | |
| 2025-06-30 | $1,767,381 | 182,581 | Shares | Defined | 2026-02-27 | |
| 2025-03-31 | $2,039,929 | 137,000 | Shares | Defined | 2026-03-17 | |
| 2024-12-31 | $1,552,320 | 104,043 | Shares | Defined | 2026-03-19 | |
| 2024-09-30 | $2,285,708 | 119,483 | Shares | Defined | 2026-03-31 | |
| 2024-06-30 | $731,681 | 35,347 | Shares | Defined | 2026-03-23 | |
| 2024-03-31 | $5,029,975 | 267,552 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $3,179,132 | 220,467 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $8,022,296 | 462,114 | Shares | Defined | 2026-03-26 | |
| 2023-06-30 | $6,875,393 | 330,389 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $1,889,054 | 80,317 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $5,161,825 | 184,813 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $3,998,357 | 170,870 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $4,779,302 | 141,609 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $9,646,545 | 276,168 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||